Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001036050-99-000637
Filing Date
1999-03-30
Accepted
1999-03-30 00:00:00
Documents
5
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 198431
2 COMPUTATION OF NET LOSS PER SHARE EX-11 1670
3 CONSENT OF KPMG EX-23 885
4 FINANCIAL DATA SCHEDULE EX-27 2062
5 CERTIFICATE OF DESIGNATION PREFERRED SHARES EX-3.2 14720
  Complete submission text file 0001036050-99-000637.txt   219607
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21699 | Film No.: 99576863
SIC: 2834 Pharmaceutical Preparations